Reappraisal of omeract 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the omeract 9 v2 criteria
Authors
Fitzgerald, O et al.Affiliation
Our Lady's Hospice & Care ServicesIssue Date
2009Keywords
RHEUMATOLOGYHOSPICE
Local subject classification
MUSCULOSKELETAL CARE